drugset / Trial / NCT02641431

Epicardial Ablation in Brugada Syndrome

NCT02641431

Completed 135 enrolled IRCCS Policlinico S. Donato
NaSingle-groupOpen-labelTreatment

Summary

This prospective study evaluates the methodology and results of epicardial mapping/ablation in a large series of consecutive selected BrS patients and to verify if RFA could normalize the consequences of a genetic disease.

Timeline

Start
2015-11-16
Primary completion
2016-12-21
Completion
2016-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Ajmaline Small molecule 1 mg/kg

Indications